lipid

1,2-Distearoyl-sn-glycero-3-phosphorylcholine (L-ALPHA-PHOSPHATIDYLCHOLINE, DISTEAROYL) is a cylindrical-shaped lipid used to synthesize liposomes. 1,2-Distearoyl-sn-glycero-3-phosphorylcholine (L-ALPHA-PHOSPHATIDYLCHOLINE, DISTEAROYL) is the lipid component in the lipid nanoparticle (LNP) system.

1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) is a synthetic phospholipid utilized in liposomes for the study of lipid monolayers and bilayers.

DOTAP chloride (1,2-Dioleoyl-3-trimethylammonium-propane chloride) is a useful and effective cationic lipid transfection DNA(plasmids, BacMIDs) and modified nucleic acids (antisense oligonucleotides) without the use of auxiliary lipids.

ALC-0159 is a polyethylene glycol (PEG) lipid conjugate that could be used as a vaccine excipient[1].

Lipid 5, an amino lipid compound, demonstrates proficient mRNA delivery in rodent and primate models, with favorable pharmacokinetics and minimal toxicity.

Lipid M (pKa: 6.75) is a potential carrier for mRNA vaccines, offering enhanced immune responses and increased tolerability [1].

Lipid 29, an ionizable amino lipid, can be utilized to create lipid nanoparticles [1].

Lipid C24, a cationic ionizable compound, plays a crucial role in creating lipid nanoparticles (LNPs) and is utilized in nucleic acid delivery research [1].

Diamino lipid DAL4 is novel lipid nanoparticles (LNPs) encapsulated with mRNAs encoding cytokines including IL-12 , IL-27 and GM-CSF . Diamino lipid DAL4 delivers mRNA to tumor cells to exert anti-tumor activity [1] .

LNP Lipid-1 (Method B), a lipid compound, plays a crucial role in the formulation of lipid nanoparticles compositions and exhibits potential for transporting biologically active substances, including small molecule agents, proteins, and nucleic acids [1] [2].

LNP Lipid-4 (Compound 8-8) is a lipid compound integral to the synthesis of lipid nanoparticle compositions, demonstrating potential for the transport of biologically active substances [1].

Lipid 14, a potent ionizable compound, is essential for synthesizing lipid nanoparticles (LNPs) [1].

mRNA-Encapsulating Lipid Excipient 1 (Compound 2), a thiocarbamate-based ionizable lipid, serves as an excipient in the formulation of mRNA-encapsulating lipid nanoparticles [1].

Lipid 10, an ionizable amino lipid, is utilized in the production of Lipid nanoparticles (LNPs).

Lipid 8, an ionizable amino lipid, is employed in the synthesis of Lipid Nanoparticles (LNPs).

Lipid 15, an ionizable amino lipid, is utilized in the production of Lipid Nanoparticles (LNPs).

LNP Lipid-7 (Compound 7013) is a lipid utilized in the formulation of lipid nanoparticles (LNP) for efficient drug delivery [1].

Ionizable Lipid-1 (compound II-10), with a pKa of 6.16, is an ionizable lipid capable of forming lipid nanoparticles (LNP) with a bilayer structure [1].

Lipid 1 is an ionizable aminolipid used in the synthesis of lipid nanoparticles.

Lipid 6 is an ionizable amino lipid (amino lipid) used for the synthesis of lipid nanoparticles (LNPs).

LNP Lipid-3 is an ionizable lipid utilized in the synthesis of lipid nanoparticles, originating from patent WO2021113777A1.

LNP Lipid-2 is a lipid product (lipid product) used for the delivery of active molecules.

LNP Lipid-5 is an ionizable lipid (amino lipid) used in the formulation of lipid nanoparticles (LNP).

LNP Lipid-6 is an ionizable lipid (amino lipid) that is utilized in the preparation of lipid nanoparticles (LNP).